当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 现金流量表

羚锐制药

(600285)

  

流通市值:129.70亿  总市值:129.98亿
流通股本:5.66亿   总股本:5.67亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,035,553,754.08895,511,232.13,825,702,138.262,576,110,565.76
  收到的税费返还--761,756.01-
  收到其他与经营活动有关的现金33,866,1777,720,867.4598,371,818.0280,405,215.11
  经营活动现金流入小计2,069,419,931.08903,232,099.553,924,835,712.292,656,515,780.87
  购买商品、接受劳务支付的现金294,403,477.76172,076,316.72714,912,160.76575,272,672.59
  支付给职工以及为职工支付的现金185,738,783.0974,714,723.82367,554,981.62270,046,463.29
  支付的各项税费276,716,164.12137,138,823.49494,167,389.55377,013,274.65
  支付其他与经营活动有关的现金956,973,999.36401,686,335.41,472,336,947.231,084,133,918.09
  经营活动现金流出小计1,713,832,424.33785,616,199.433,048,971,479.162,306,466,328.62
  经营活动产生的现金流量净额355,587,506.75117,615,900.12875,864,233.13350,049,452.25
二、投资活动产生的现金流量:
  收回投资收到的现金23,941,820.1523,352,833.0935,697,360.1721,111,487.56
  取得投资收益收到的现金16,374,701.6914,514,191.7920,161,914.211,585,397.49
  处置固定资产、无形资产和其他长期资产收回的现金净额7,185,162323,00017,85015,000
  处置子公司及其他营业单位收到的现金净额-822,114.54--
  收到的其他与投资活动有关的现金146,500,000120,000,000410,000,0001,110,000,000
  投资活动现金流入小计194,001,683.84159,012,139.42465,877,124.381,132,711,885.05
  购建固定资产、无形资产和其他长期资产支付的现金32,618,221.3511,743,474.69115,110,392.1833,615,094.21
  投资支付的现金20,000,000-10,000,00010,000,000
  取得子公司及其他营业单位支付的现金672,549,843.75672,549,843.75--
  支付其他与投资活动有关的现金397,492,610260,492,6101,006,599,055.541,706,599,055.55
  投资活动现金流出小计1,122,660,675.1944,785,928.441,131,709,447.721,750,214,149.76
  投资活动产生的现金流量净额-928,658,991.26-785,773,789.02-665,832,323.34-617,502,264.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金--35,141,322-
  取得借款收到的现金398,070,362.2911,340,271.8940,433,003.910,972,968.09
  收到其他与筹资活动有关的现金--8,619,222.748,619,222.74
  筹资活动现金流入小计398,070,362.2911,340,271.8984,193,548.6419,592,190.83
  偿还债务支付的现金10,000,000-102,844,440.2120,000,000
  分配股利、利润或偿付利息支付的现金509,986,252.9414,611.12451,344,714.03448,680,272.42
  支付其他与筹资活动有关的现金1,052,511.05202,9771,942,276.361,295,559.88
  筹资活动现金流出小计521,038,763.95617,588.12556,131,430.6469,975,832.3
  筹资活动产生的现金流量净额-122,968,401.6610,722,683.77-471,937,881.96-450,383,641.47
四、汇率变动对现金及现金等价物的影响-18,920.46-12,982.27,770.61-3,101.42
五、现金及现金等价物净增加额-696,058,806.63-657,448,187.33-261,898,201.56-717,839,555.35
  加:期初现金及现金等价物余额1,228,377,8061,228,377,8061,490,276,007.561,490,276,007.56
  期末现金及现金等价物余额532,318,999.37570,929,618.671,228,377,806772,436,452.21
补充资料:
  净利润475,868,499.88-722,584,691.99-
  资产减值准备35,682.24-501,754.11-
  固定资产和投资性房地产折旧33,229,438.81-60,753,162.81-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,229,438.81-60,753,162.81-
  无形资产摊销11,536,163.03-10,984,589.09-
  长期待摊费用摊销1,403,350.56-2,686,349.5-
  处置固定资产、无形资产和其他长期资产的损失-4,703,827.72--12,061.9-
  固定资产报废损失93,037.72-3,911,232.06-
  公允价值变动损失1,998,717.96-10,490.56-
  财务费用1,608,648.59-661,121.11-
  投资损失-24,131,253.21--40,214,203.52-
  递延所得税-7,023,107.22--220,901.18-
  其中:递延所得税资产减少-9,114,102.39--11,326,243.92-
    递延所得税负债增加2,090,995.17-11,105,342.74-
  存货的减少59,239,026.45-31,877,421.29-
  经营性应收项目的减少-235,881,828.29-17,405,825.85-
  经营性应付项目的增加20,994,518.89-52,425,235.42-
  其他13,318,874.18-4,984,179.22-
  现金的期末余额532,318,999.37-1,228,377,806-
  减:现金的期初余额1,228,377,806-1,490,276,007.56-
  现金及现金等价物的净增加额-696,058,806.63--261,898,201.56-
公告日期2025-08-202025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑